Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
European Pharmaceutical Journal
Volume 66 (2019): Issue 1 (June 2019)
Open Access
Hippocampal electrophysiological responses and changes in oxidative stress marker and serum lipid profile to pharmacological and non-pharmacological treatments of high-fat-fructose diet induced metabolic syndrome
D. Micháliková
D. Micháliková
,
B. Tyukos Kaprinay
B. Tyukos Kaprinay
,
M. Sasváriová
M. Sasváriová
,
K. Švík
K. Švík
,
L. Slovák
L. Slovák
,
R. Sotníková
R. Sotníková
,
T. Stankovičová
T. Stankovičová
and
Z. Gáspárová
Z. Gáspárová
| Dec 26, 2019
European Pharmaceutical Journal
Volume 66 (2019): Issue 1 (June 2019)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Dec 26, 2019
Page range:
32 - 37
Received:
Apr 14, 2018
Accepted:
Jun 01, 2018
DOI:
https://doi.org/10.2478/afpuc-2019-0007
Keywords
metabolic syndrome
,
high-fat-fructose diet
,
hippocampus
,
cholesterol
,
oxidative stress
,
rosmarinic acid
,
caloric restriction
© 2019 D. Micháliková et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
D. Micháliková
Slovak Academy of Sciences, Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology,
Bratislava
Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin
Martin
B. Tyukos Kaprinay
Slovak Academy of Sciences, Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology,
Bratislava
M. Sasváriová
Comenius University in Bratislava, Pharmaceutical Faculty, Bratislava
K. Švík
Slovak Academy of Sciences, Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology,
Bratislava
L. Slovák
Slovak Academy of Sciences, Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology,
Bratislava
R. Sotníková
Slovak Academy of Sciences, Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology,
Bratislava
T. Stankovičová
Comenius University in Bratislava, Pharmaceutical Faculty, Bratislava
Z. Gáspárová
Slovak Academy of Sciences, Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology,
Bratislava